Invuity, Inc. (NASDAQ:IVTY) has been given a consensus rating of “Buy” by the nine analysts that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $15.50.

IVTY has been the topic of a number of analyst reports. Northland Securities reissued a “buy” rating and issued a $13.00 price target on shares of Invuity in a research note on Tuesday, May 16th. Zacks Investment Research lowered Invuity from a “hold” rating to a “sell” rating in a research report on Tuesday, June 13th. William Blair restated a “buy” rating on shares of Invuity in a research report on Tuesday, May 23rd. Finally, Stifel Nicolaus restated a “buy” rating and set a $10.00 price objective (up from $9.00) on shares of Invuity in a research report on Thursday, April 27th.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/06/19/invuity-inc-ivty-given-average-rating-of-buy-by-analysts.html.

In other news, Director Reza Zadno sold 4,000 shares of Invuity stock in a transaction dated Wednesday, May 3rd. The stock was sold at an average price of $9.16, for a total transaction of $36,640.00. Following the completion of the sale, the director now directly owns 8,800 shares in the company, valued at approximately $80,608. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Eric W. Roberts purchased 5,000 shares of Invuity stock in a transaction dated Monday, May 15th. The shares were purchased at an average price of $7.88 per share, with a total value of $39,400.00. Following the completion of the acquisition, the director now owns 101,529 shares in the company, valued at $800,048.52. The disclosure for this purchase can be found here. Insiders have acquired a total of 13,500 shares of company stock valued at $102,955 over the last 90 days. Corporate insiders own 13.84% of the company’s stock.

Large investors have recently made changes to their positions in the stock. Royce & Associates LP purchased a new stake in shares of Invuity during the fourth quarter valued at about $128,000. Trexquant Investment LP purchased a new stake in shares of Invuity during the fourth quarter valued at about $184,000. Alyeska Investment Group L.P. purchased a new stake in shares of Invuity during the fourth quarter valued at about $856,000. Deerfield Management Co. raised its stake in shares of Invuity by 31.8% in the fourth quarter. Deerfield Management Co. now owns 1,690,498 shares of the medical instruments supplier’s stock valued at $9,720,000 after buying an additional 407,900 shares in the last quarter. Finally, RTW Investments LP raised its stake in shares of Invuity by 15.8% in the fourth quarter. RTW Investments LP now owns 454,900 shares of the medical instruments supplier’s stock valued at $2,616,000 after buying an additional 62,062 shares in the last quarter. Institutional investors and hedge funds own 69.41% of the company’s stock.

Invuity (IVTY) traded up 8.94% during midday trading on Monday, hitting $6.70. 97,119 shares of the company traded hands. The stock has a 50 day moving average of $7.73 and a 200 day moving average of $7.34. Invuity has a 12-month low of $4.50 and a 12-month high of $14.25. The stock’s market cap is $113.73 million.

Invuity (NASDAQ:IVTY) last released its earnings results on Wednesday, April 26th. The medical instruments supplier reported ($0.64) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.61) by $0.03. The firm had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.71 million. Invuity had a negative return on equity of 129.81% and a negative net margin of 118.92%. Equities research analysts predict that Invuity will post ($2.24) EPS for the current fiscal year.

About Invuity

Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.